“Research continues to expand our understanding of the causes of, treatments for, and prevention of Alzheimers disease. Basic research elucidates the molecular and cellular process underlying AD, allowing the identification of potential targets for intervention. Through the drug development process and the translation of behavioral interventions, treatments are tested in preclinical experiments for their effectiveness. Promising interventions are further refined and tested to ensure they are safe and effective for the public. While the ultimate goals are to develop effective prevention and treatment modalities by 2025, ongoing research and clinical inquiry can inform our ability to delay onset of Alzheimers disease, minimize its symptoms, and delay its progression. Under this goal, HHS will prioritize and accelerate the pace of scientific research and ensure that as evidence-based solutions are identified they are quickly translated, put into practice, and brought to scale so that individuals with Alzheimers disease can benefit from increases in scientific knowledge.”
Sorry, comments are closed for this post.